|
Home
About Us
eMedicine Search
Drug Development
Feedback
Google Scholar Search
Intranet |
|
Literature DatabaseThis section of our site provides information regarding some of the topics closely associated to our current or planned research projects; please use the links below to access information regarding the specific topics:
Neurodegenerative diseases such as Alzheimer's disease (AD), Multiple Sclerosis (MS), or Parkinson's disease (PD) are characterized by progressive loss of neurons which, over time, leads to neurodegeneration and resulting disability.
Cell membranes consist of a bilayer primarily
composed of various phospholipids, cholesterol, and integral (imbedded)
proteins that function as cell-surface receptors, enzymes, and various
transporters. The fatty acid (FA) composition of phospholipids
determines biophysical (and functional) characteristics of membranes
(e.g., membrane "fluidity"), and plays an important role in cellular
integrity, and intra and intercellular communication (signaling).
Furthermore, there is abundant literature evidence (see below) that essential
fatty acids (EFAs), and especially polyunsaturated fatty acids
(PUFAs), such as docosahexaenoic
acid (DHA)1 and
eicosapentaenoic acid (EPA)2
(see Figure 1),
play fundamental role in development and proper functioning of the nervous
system; consequently, the EFA composition of membrane phospholipids
likely plays a direct role in a variety of cellular and multicellular processes,
including inflammation and immunity, with implications for neurodegenerative
diseases. The links below provide recent literature overview of
relevant topics. Please note that the links below lead to published references selected by the keyword(s) associated with a given link; e.g., the "Cortisol reviews" link below contains 92 references found using the search keywords "cortisol" and selecting for "review" references published in 2003-2004.
1Docosahexaenoic acid or
DHA is an omega-3 fatty acid with six cis double bonds and 22
carbons (22:6n-3).
Figure 1. Chemical structure of eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
ALS Therapy Development Foundation Multiple Sclerosis: Hope Through Research Neurological Disorder Information
Site designed, updated and maintained by Robert Bieganski
Enhanced by
Neuroinformation
|